Epigral Ltd. (EPIGRAL) — Capital Reinvestment Ratio
Latest as of September 2025:
0.88x
Epigral Ltd. (EPIGRAL) has a Capital Reinvestment Ratio of 0.88x as of September 2025, meaning it reinvests 1% of its operating cash flow (Rs2.67 Billion) in capital expenditures (Rs2.36 Billion). See Epigral Ltd. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.88x
Capex / Operating Cash Flow
Operating Cash Flow
Rs2.67 Billion
INR
Capital Expenditures
Rs2.36 Billion
INR
Data as of
Sep 2025
Most recent filing
Epigral Ltd. Capital Reinvestment Ratio (2015–2026)
This chart tracks Epigral Ltd.'s Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Epigral Ltd. (2015–2026)
Year-by-year Capital Reinvestment Ratio for Epigral Ltd. from 2015 to 2026. For live market cap and broader valuation context, see Epigral Ltd. (EPIGRAL) total market value.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 1.02x | Rs3.88 Billion | Rs3.94 Billion | ▲ +130.1% |
| 2025 | 0.44x | Rs4.41 Billion | Rs1.95 Billion | ▼ -55.9% |
| 2024 | 1.00x | Rs3.98 Billion | Rs3.98 Billion | ▲ +50.7% |
| 2023 | 0.67x | Rs6.26 Billion | Rs4.16 Billion | ▼ -58.6% |
| 2022 | 1.61x | Rs2.84 Billion | Rs4.56 Billion | ▲ +87.3% |
| 2021 | 0.86x | Rs2.29 Billion | Rs1.97 Billion | ▼ -61.7% |
| 2020 | 2.24x | Rs1.65 Billion | Rs3.69 Billion | ▲ +93.6% |
| 2019 | 1.16x | Rs2.61 Billion | Rs3.03 Billion | ▲ +110.9% |
| 2018 | 0.55x | Rs2.25 Billion | Rs1.23 Billion | ▲ +117.6% |
| 2017 | 0.25x | Rs1.38 Billion | Rs349.30 Million | ▼ -46.8% |
| 2016 | 0.47x | Rs1.23 Billion | Rs585.42 Million | ▲ +1443.4% |
| 2015 | 0.03x | Rs1.12 Billion | Rs34.48 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow